Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00585702 · ClinicalTrials.gov registry record
Antimanic Drug Use in Pregnancy
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 201
- Enrollment target
NCT00585702: Completed study, sponsored by University of Pittsburgh.
NCT00585702 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 201 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00585702 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 201 participants
- Enrollment target
Study Summary
The purpose of this study is to learn about the effects of bipolar disorder or the use of antimanic medications on the mother's health and wellbeing during pregnancy and for the first postpartum year. Infant health and development are also assessed during the first year. Participation in the study includes 7 study visits, three in pregnancy and four postpartum.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 201 participants |
| Start Date | 2006-08 |
| Est. Completion | 2012-03 |
What the finished NCT00585702 record still lists
NCT00585702 is an observational study that tracks outcomes without assigning an intervention. The registered 201 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00585702 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00585702 about?
NCT00585702 is a clinical study titled "Antimanic Drug Use in Pregnancy". The purpose of this study is to learn about the effects of bipolar disorder or the use of antimanic medications on the mother's health and wellbeing during pregnancy and for the first postpartum year. Infant health and development are also assessed during the first year. Participation in the study i...
What is the current status of trial NCT00585702?
This trial is currently completed. The enrollment target is 201 participants. The study started on 2006-08. Estimated completion is 2012-03.
Who is sponsoring clinical trial NCT00585702?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04422652 · 201 participants · Phase 2
Combination of Novel Therapies for CKD Comorbid Depression
- NCT05327114 · 201 participants · Phase 2
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- NCT06099769 · 201 participants · Phase 2
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
- NCT06274528 · 201 participants · Phase 2
DORA and LP in Alzheimer's Disease Biomarkers
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia